These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38101681)

  • 1. Systematic identification and repurposing of FDA-approved drugs as antibacterial agents against Streptococcus pyogenes: In silico and in vitro studies.
    Gracia J; Perumal D; Dhandapani P; Ragunathan P
    Int J Biol Macromol; 2024 Feb; 257(Pt 2):128667. PubMed ID: 38101681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study.
    Singh AK; Kushwaha PP; Prajapati KS; Shuaib M; Gupta S; Kumar S
    Comput Biol Med; 2021 Mar; 130():104185. PubMed ID: 33352458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
    Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
    J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling on streptolysin-O of multidrug resistant Streptococcus pyogenes and computer aided screening and in vitro assay for novel herbal inhibitors.
    Skariyachan S; Narayan NS; Aggimath TS; Nagaraj S; Reddy MS; Narayanappa R
    Curr Comput Aided Drug Des; 2014 Mar; 10(1):59-74. PubMed ID: 24694051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational prognostic evaluation of Alzheimer's drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches.
    Hassan M; Shahzadi S; Yasir M; Chun W; Kloczkowski A
    Sci Rep; 2023 Oct; 13(1):18022. PubMed ID: 37865690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential inhibitors against FemX of Staphylococcus aureus: A hierarchial in-silico drug repurposing approach.
    Rahman S; Rajak K; Mishra S; Das AK
    J Mol Graph Model; 2022 Sep; 115():108215. PubMed ID: 35636337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico Core Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against
    Rehman A; Wang X; Ahmad S; Shahid F; Aslam S; Ashfaq UA; Alrumaihi F; Qasim M; Hashem A; Al-Hazzani AA; Abd Allah EF
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769873
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudouridimycin-A Potent Nucleoside Inhibitor of the RNA Polymerase Beta Prime Subunit of
    Pavundurai Chandra K; Perumal D; Ragunathan P
    ACS Omega; 2023 Feb; 8(8):7989-8000. PubMed ID: 36873015
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
    Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
    Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Drug Repurposing Approach: Investigation of
    Ngidi NTP; Machaba KE; Mhlongo NN
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163931
    [No Abstract]   [Full Text] [Related]  

  • 11. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
    Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug repurposing against the RNA-dependent RNA polymerase domain of dengue serotype 3 by virtual screening and molecular dynamics simulations.
    Gangopadhyay A; Saha A
    J Biomol Struct Dyn; 2023 Jul; 41(11):5152-5165. PubMed ID: 35642087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Citral and Phloretin, Alone and in Combination, on Major Virulence Traits of
    Adil M; Baig MH; Rupasinghe HPV
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766432
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification and prioritization of promising lead molecules from
    Mangal P; Jha RK; Jain M; Singh AK; Muthukumaran J
    J Biomol Struct Dyn; 2023; 41(12):5418-5435. PubMed ID: 35706070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
    Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
    Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target-based drug repurposing against Candida albicans-A computational modeling, docking, and molecular dynamic simulations study.
    Verma R; Pradhan D; Nayek A; Singh H; Jain AK; Khan LA
    J Cell Biochem; 2022 Feb; 123(2):289-305. PubMed ID: 34672012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep-learning based repurposing of FDA-approved drugs against
    Joshi T; Pundir H; Chandra S
    J Biomol Struct Dyn; 2022 Nov; 40(18):8420-8436. PubMed ID: 33879017
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.